36 - Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

16/08/2024 24 min Temporada 1 Episodio 36

Ouvir "36 - Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma"

Descargar episodio Ver en sitio original

Sinopse do Episódio

Discussão do artigo: "Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma" de Melani C NEJM 2024
Apresentado por: Dra. Aline Guerra
Discussão por: Dr. Lucas Salviano, Dr. Breno Aires, Dr. Pedro Arruda e Dr. Vinicius Molla

Mais episódios do podcast TMO EPM / Hemato H9J

65 - Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma 05/11/2025

64 - Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin 02/11/2025

63 - Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT 01/09/2025

62 - Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation 10/08/2025

61 - Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study 04/08/2025

60 - Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 27/07/2025

59 - Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation 23/07/2025

58 - Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised,double-blind, placebo controlled, phase 3 study 13/07/2025

57 - A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults 06/07/2025

56 - Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities 29/06/2025

Ver todos los episodios